Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07782814 | An Investigation Into Dielectric Testing for the Evaluation and Characterisation of Breast Tissue Using a Novel Time-Domain Bioimpedance Tool(DiTECT) | not yet recruiting | — | 220 | Zedsen LimitedINDUSTRY | 1 | Aug 27, 2026 | clinicaltrials |
| NCT07791368 | Developing and Testing the Efficacy of AI-Chatbot-Based | not yet recruiting | N/A | 68 | National Taiwan University HospitalOTHER | 1 | Aug 27, 2026 |
| clinicaltrials |
| NCT04430595 | Multi-4SCAR-T Therapy Targeting Breast Cancer | not yet recruiting | Phase 1 / Phase 2 | 100 | Shenzhen Geno-Immune Medical InstituteOTHER | 1 | Aug 26, 2026 | clinicaltrials |
| NCT07729956 | A Study of BL-B01D1 Plus an Anti-PD-1 Antibody Versus Nab-paclitaxel Plus an Anti-PD-1 Antibody in Patients With Previously Untreated, Locally Advanced, Inoperable or Metastatic Triple-Negative Breast Cancer Whose Tumors Express PD-L1 (PANKU-Breast04) | not yet recruiting | Phase 3 | 436 | Sichuan Baili Pharmaceutical Co., Ltd.INDUSTRY | 1 | Aug 26, 2026 | clinicaltrials |
| NCT07782840 | QL1706 Plus Neoadjuvant Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer With a Poor Response to Neoadjuvant Chemotherapy | not yet recruiting | Phase 2 | 40 | Hebei Medical University Fourth HospitalOTHER | 0 | Aug 26, 2026 | clinicaltrials |
| NCT07786428 | Tailored Neoadjuvant Chemoimmunotherapy for Stage I TNBC(DETENTE-1) | not yet recruiting | Phase 2 | 60 | University of Texas Southwestern Medical CenterOTHER | 1 | Aug 26, 2026 | clinicaltrials |
| NCT07787338 | SHR-A1811 Monotherapy or Sequential THPy as Neoadjuvant Therapy for Stage II-III HER2-Positive Breast Cancer | not yet recruiting | Phase 2 | 80 | First Affiliated Hospital of Zhejiang UniversityOTHER | 1 | Aug 26, 2026 | clinicaltrials |
| NCT07788222 | Sacituzumab Govitecan and Q901 in Advanced TNBC | not yet recruiting | Phase 2 | 48 | Yonsei UniversityOTHER | 0 | Aug 26, 2026 | clinicaltrials |
| NCT07784036 | JYP0035 Capsules Plus Fulvestrant in PIK3CA-Mutant HR+/HER2- Advanced Breast Cancer | not yet recruiting | Phase 3 | 171 | Chengdu JOYO pharma Co., Ltd.INDUSTRY | 0 | Aug 25, 2026 | clinicaltrials |
| NCT07786051 | DiEtary Mimicry by Glucocorticoid Modulation Evaluation in ER+ Metastatic Breast Cancer Treatment: Efficacy and Response (DEMETER Trial)(DEMETER) | not yet recruiting | Phase 2 | 80 | The Netherlands Cancer InstituteOTHER | 0 | Aug 25, 2026 | clinicaltrials |
| NCT07596212 | BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder | not yet recruiting | Phase 1 / Phase 2 | 100 | University of Illinois at ChicagoOTHER | 1 | Aug 24, 2026 | clinicaltrials |
| NCT07659652 | Quality of Life for Patients With Breast Cancer Brain Metastases and Leptomeningeal Disease | not yet recruiting | — | 200 | University of California, San FranciscoOTHER | 1 | Aug 24, 2026 | clinicaltrials |
| NCT07781163 | Evaluation of the Safety and Efficacy of Single-Port Robot-Assisted Endoscopic Breast-Conserving Surgery and Nipple-sparing Matectomy With Reconstruction in Early-Stage Breast Cancer Patients | not yet recruiting | N/A | 30 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 0 | Aug 24, 2026 | clinicaltrials |
| NCT07782086 | A Study of T-DXd in AI-Assessed HER2-Ultralow Metastatic Breast Cancer(Veri-HER2UL) | not yet recruiting | N/A | 30 | Shuangyue LiuOTHER | 1 | Aug 24, 2026 | clinicaltrials |
| NCT07553390 | Phase 1b Study Of TRICK-NK In Combination With T-Dxd In Treatment-Refractory Breast Cancers | not yet recruiting | Phase 1 | 60 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 19, 2026 | clinicaltrials |
| NCT07558343 | Male breAsT cAncer preDisposition Factor: Creation of a Control Cohort 2(MATADOR2) | not yet recruiting | N/A | 120 | Institut Claudius RegaudOTHER | 1 | Aug 19, 2026 | clinicaltrials |
| NCT07774624 | Study of SKB103 in HER2-negative Breast Cancer | not yet recruiting | Phase 1 / Phase 2 | 140 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.INDUSTRY | 0 | Aug 19, 2026 | clinicaltrials |
| NCT07775014 | Percutaneous Cryoablation for the Treatment of Breast Cancer(CRYSTAL) | not yet recruiting | N/A | 50 | Ospedale CottolengoOTHER | 1 | Aug 19, 2026 | clinicaltrials |
| NCT07529353 | Feasibility of 'Exercise for CAncer Patients and Healthy EAting Timeframes' .(EXCAP-hEAT) | not yet recruiting | N/A | 20 | University of RochesterOTHER | 1 | Aug 17, 2026 | clinicaltrials |
| NCT07767565 | Research on the Development and Validation of Personalized Exercise Prescription System for Breast Cancer Patients Based on Large Language Models | not yet recruiting | — | 40 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Aug 17, 2026 | clinicaltrials |
| NCT07766772 | Trastuzumab Rezetecan Followed by Pyrotinib, and Trastuzumab Combined With Capecitabine as First-line Treatment for Advanced HER2-positive Breast Cancer | not yet recruiting | Phase 2 | 50 | Fujian Cancer HospitalOTHER_GOV | 1 | Aug 14, 2026 | clinicaltrials |
| NCT07763756 | Single vs Multiple Injection Intertransverse Process Block in Breast Cancer Surgery | not yet recruiting | N/A | 60 | Antalya City HospitalOTHER | 0 | Aug 13, 2026 | clinicaltrials |
| NCT07272642 | A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tumors.(DUNP19) | not yet recruiting | Phase 1 | 16 | Radiopharm Theranostics, LtdINDUSTRY | 1 | Aug 12, 2026 | clinicaltrials |
| NCT07549139 | Overcoming Racial Disparities in Screening Mammography | not yet recruiting | N/A | 176 | Washington University School of MedicineOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT07760844 | An Open-Label, Randomized Phase III Study of Trastuzumab Rezetecan With or Without Everolimus in First to Third Line LAR Subtype TNBC(SCHBCC-N0117) | not yet recruiting | Phase 3 | 180 | Fudan UniversityOTHER | 0 | Aug 12, 2026 | clinicaltrials |
| NCT07761325 | Aromatherapy Combined With Standard Antiemetic Therapy vs Standard Therapy Alone for Prevention of CINV in Breast Cancer Patients Receiving Highly Emetogenic Chemotherapy | not yet recruiting | Phase 3 | 374 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Aug 12, 2026 | clinicaltrials |
| NCT07757074 | A Comparative Study of Delayed Endoscopic DTI and Latissimus Dorsi ±Impalnt Reconstruction Post-Mastectomy(DELTI) | not yet recruiting | — | 268 | Du ZhengguiOTHER | 1 | Aug 11, 2026 | clinicaltrials |
| NCT07757230 | A Phase II Study of SSGJ-612 Plus a HER2-Targeted ADC in HR-Positive, HER2-Low or HER2-Ultralow Expression Metastatic Breast Cancer | not yet recruiting | Phase 2 | 87 | Shenyang Sunshine Pharmaceutical Co., LTD.INDUSTRY | 1 | Aug 11, 2026 | clinicaltrials |
| NCT07757958 | Partial Breast Irradiation Without Sentinel Lymph Node Biopsy in Low-Risk Early Breast Cancer(APROOB) | not yet recruiting | Phase 3 | 520 | Samsung Medical CenterOTHER | 1 | Aug 11, 2026 | clinicaltrials |
| NCT07752550 | Retlirafusp Alfa Combined With Chemotherapy or Fuzuloparib for Triple-Negative Breast Cancer | not yet recruiting | Phase 2 | 120 | Harbin Medical UniversityOTHER | 1 | Aug 7, 2026 | clinicaltrials |
| NCT07752875 | A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation | not yet recruiting | Phase 1 / Phase 2 | 250 | LG ChemINDUSTRY | 0 | Aug 7, 2026 | clinicaltrials |
| NCT07750340 | Breast Cancer Molecular Subtypes and Skeletal Metastases Patterns on Bone Scintigraphy | not yet recruiting | — | 100 | Sohag UniversityOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT07178730 | NeoAdjuvant Therapy Comparing Sacituzumab Govitecan+Pembrolizumab vs. SoC Chemotherapy in Clinical Stage II-III, Triple-negative Early Breast Cancer(ADAPT-TN-IV) | not yet recruiting | Phase 3 | 765 | Women's Cancer Study Group GmbHOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT07552181 | Phase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in Patients With Early Stage Triple Negative Breast Cancer | not yet recruiting | Phase 2 | 50 | Yuan YuanOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT07748260 | De-escalation Neoadjuvant Therapy for Intermediate Risk HER2-positive Early Breast(neoDIRHP) | not yet recruiting | Phase 3 | 592 | Guangdong Provincial People's HospitalOTHER | 0 | Aug 5, 2026 | clinicaltrials |
| NCT07743632 | Neoadjuvant Angiogenesis-Targeting Bispecific Chemoimmunotherapy for TNBC(NeoASPECT) | not yet recruiting | Phase 2 | 110 | University of Kansas Medical CenterOTHER | 0 | Aug 4, 2026 | clinicaltrials |
| NCT07745023 | Mind-Body Interventions for the Improvement of Quality of Life, Stress, and Sleep Quality Among Survivors of Breast, Prostate, Endometrial, or Colorectal Cancer | not yet recruiting | N/A | 30 | Roswell Park Cancer InstituteOTHER | 0 | Aug 4, 2026 | clinicaltrials |
| NCT07151586 | Testing Two Different Drugs (Sacituzumab-govitecan and Trastuzumab-deruxtecan) Combinations Prescribed in an Alterning Pattern to Patients With Metastatic or Locally Advanced Triple-negative Breast Cancer(ALTER) | not yet recruiting | Phase 2 | 260 | UNICANCEROTHER | 1 | Aug 3, 2026 | clinicaltrials |
| NCT07728565 | Long-term Evaluation of Quality of Life and Aesthetic Outcomes After Autologous Breast Reconstruction Using the Profunda Artery Perforator (PAP) Flap(QUALIPAP) | not yet recruiting | — | 264 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Aug 3, 2026 | clinicaltrials |
| NCT07742969 | The Effect of Dyadic Self-Care Education Provided to Breast Cancer Patient-Caregiver Dyads on Patient and Caregiver Outcomes | not yet recruiting | N/A | 156 | Ulviye Aydan NACAKOTHER | 0 | Aug 3, 2026 | clinicaltrials |
| NCT07735897 | Long Term Cohort Study of Adding Ovarian Function Suppression to Tamoxifen in Young Women(ASTRRAIV) | not yet recruiting | — | 1,483 | MedicalExcellenceOTHER | 1 | Jul 31, 2026 | clinicaltrials |
| NCT07738341 | GB268 Monotherapy or Combination Therapy for Locally Advanced/Metastatic Breast Cancer (Phase Ib/Ⅱ) | not yet recruiting | Phase 1 / Phase 2 | 270 | Eddingpharm (Zhuhai) Co., Ltd.INDUSTRY | 0 | Jul 31, 2026 | clinicaltrials |
| NCT07737132 | Comparison of Postoperative Analgesic Efficacy of Two Different Blocks in Modified Radical Mastectomy Surgery(mastectomy) | not yet recruiting | N/A | 70 | Sultan Abdulhamid Han Training and Research Hospital, Istanbul, TurkeyOTHER | 0 | Jul 30, 2026 | clinicaltrials |
| NCT07232056 | Geriatric Oncology Assessment and Coping Skills Training for Older Women on Aromatase Inhibitor Therapy(GOAL-AI) | not yet recruiting | N/A | 452 | Duke UniversityOTHER | 0 | Jul 29, 2026 | clinicaltrials |
| NCT07732686 | Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry | not yet recruiting | — | 2,000 | University of OklahomaOTHER | 1 | Jul 29, 2026 | clinicaltrials |
| NCT07732101 | Exercise Intervention for Breast Cancer Patients With Sarcopenia(EX-BCSarc) | not yet recruiting | N/A | 104 | Capital Medical UniversityOTHER | 1 | Jul 28, 2026 | clinicaltrials |
| NCT07729046 | Neu Direction: Testing the Efficacy of Adding HER Inhibition to Standard of Care in Metastatic MLH1-low Endocrine-resistant ER+/HER2- Breast Cancer | not yet recruiting | Phase 2 | 150 | University of California, San DiegoOTHER | 1 | Jul 27, 2026 | clinicaltrials |
| NCT07458113 | Sac-TMT for Active TNBC Brain Metastases(BERLIN) | not yet recruiting | Phase 2 | 20 | Yale UniversityOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT07724769 | De-escalation of RNI in Breast Cancer Patients With pN0 After Neoadjuvant Therapy(OMIT-RNI) | not yet recruiting | N/A | 100 | Aya Ahmed SayedOTHER | 0 | Jul 24, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Aug 27, 2026source: clinicaltrials